To test the hypothesis that inhibition of offspring angiogenesis by maternal undernutrition (MUN) is mediated by maternal glucocorticoids, 3 groups of dams were studied: controls received ad libitum food; MUN dams were food restricted by 50% from day 10 of gestation; and metyrapone (MET) dams were food restricted and treated with 0.5 mg/mL of MET, a glucocorticoid synthesis inhibitor. The MUN reduced birth weights, reduced vascular endothelial growth factor (VEGF) abundance in P1 aortas, reduced VEGF and VEGF-R2 abundances in P1 mesenteric arterioles, reduced arteriolar endothelial nitric oxide synthase abundance, reduced microvessel density in the anterior tibialis, reduced endothelial cell branching in culture, reduced arteriolar immunoreactivity for proliferating cell nuclear antigen (PCNA), increased active caspase 3 in P1 mesenteric arterioles, and decreased matrix metalloproteinase (MMP)-2 and MMP-9 abundances in lysates of P1 aortas. All of these effects were prevented by treatment with metyrapone. Collectively, these findings suggest that reduced angiogenesis in MUN offspring involves direct inhibitory effects of maternal glucorticoid on fetal VEGF and its receptors.
BarkerDJOsmondCGoldingJKuhDWadsworthME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298(6673):564–567.
2.
TareMParkingtonHCBubbKJWlodekME. Uteroplacental insufficiency and lactational environment separately influence arterial stiffness and vascular function in adult male rats. Hypertension. 2012;60(2):378–386.
3.
McMillenICRobinsonJS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85(2):571–633.
4.
HarrisASecklJ. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011;59(3):279–289.
5.
Langley-EvansSCMcMullenS. Developmental origins of adult disease. Med Princ Pract. 2010;19(2):87–98.
6.
MoritzKButkusAHantzisVPeersAWintourEMDodicM. Prolonged low-dose dexamethasone, in early gestation, has no long-term deleterious effect on normal ovine fetuses. Endocrinology. 2002;143(4):1159–1165.
GardnerDSJacksonAALangley-EvansSC. Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids. Hypertension. 1997;30(6):1525–1530.
9.
Langley-EvansSC. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens. 1997;15(5):537–544.
10.
BerryLMPolkDHIkegamiMJobeAHPadburyJFErvinMG. Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol. 1997;272(6 pt 2):R1972–R1979.
11.
Langley-EvansSC. Intrauterine programming of hypertension by glucocorticoids. Life Sci. 1997;60(15):1213–1221.
KhorramOKhorramNMomeniM. Maternal undernutrition inhibits angiogenesis in the offspring: a potential mechanism of programmed hypertension. Am J Physiol Regul Integr Comp Physiol. 2007;293(2):R745–R753.
SaneDCAntonLBrosnihanKB. Angiogenic growth factors and hypertension. Angiogenesis. 2004;7(3):193–201.
16.
LevineRJMaynardSEQianC. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
17.
MaynardSEMinJYMerchanJ. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
18.
TranEDSchmid-SchonbeinGW. An in-vivo analysis of capillary stasis and endothelial apoptosis in a model of hypertension. Microcirculation. 2007;14(8):793–804.
19.
VogtCJSchmid-SchonbeinGW. Microvascular endothelial cell death and rarefaction in the glucocorticoid-induced hypertensive rat. Microcirculation. 2001;8(2):129–139.
20.
HoodJDMeiningerCJZicheMGrangerHJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998;274(3 pt 2):H1054–H1058.
21.
HorowitzJRRivardAvan der ZeeR. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol. 1997;17(11):2793–2800.
22.
LankhorstSKappersMHvan EschJHDanserAHvan den MeirackerAH. Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1. J Hypertens. 2012;31(3):444–454.
23.
SmithJTWaddellBJ. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology. 2000;141(7):2422–2428.
24.
DesaiMGayleDBabuJRossMG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol. 2005;288(1): R91–R96.
25.
KhorramOMomeniMDesaiMRossMG. Nutrient restriction in utero induces remodeling of the vascular extracellular matrix in rat offspring. Reprod Sci. 2007;14(1):73–80.
26.
AldridgeGMPodrebaracDMGreenoughWTWeilerIJ. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods. 2008;172(2):250–254.
27.
MageeJCStoneAEOldhamKTGuiceKS. Isolation, culture, and characterization of rat lung microvascular endothelial cells. Am J Physiol. 1994;267(4 pt 1):L433–L441.
PladysPSennlaubFBraultS. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005;289(6):R1580–R1588.
30.
GrigoreDOjedaNBAlexanderBT. Sex differences in the fetal programming of hypertension. Gend Med. 2008;5(suppl A):S121–S132.
31.
OzakiTNishinaHHansonMAPostonL. Dietary restriction in pregnant rats causes gender-related hypertension and vascular dysfunction in offspring. J Physiol. 2001;530(pt 1):141–152.
32.
WoodsLLIngelfingerJRNyengaardJRRaschR. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res. 2001;49(4):460–467.
33.
WoodsLLIngelfingerJRRaschR. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R1131–R1136.
34.
WoodsLLWeeksDARaschR. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004;65(4):1339–1348.
LesageJBlondeauBGrinoMBreantBDupouyJP. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 2001;142(5):1692–1702.
37.
BertramCTrowernARCopinNJacksonAAWhorwoodCB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology. 2001;142(7):2841–2853.
38.
Langley-EvansSCPhillipsGJBenediktssonR. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta. 1996;17(2-3):169–172.
39.
WyrwollCSSecklJRHolmesMC. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology. 2009;150(3):1287–1293.
40.
DeLanoFASchmid-SchonbeinGW. Enhancement of glucocorticoid and mineralocorticoid receptor density in the microcirculation of the spontaneously hypertensive rat. Microcirculation. 2004;11(1):69–78.
41.
IwaiAFujiiYKawakamiS. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Mol Cell Endocrinol. 2004;226(1-2):11–17.
SminkJJBuchholzIMHamersN. Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis. Osteoarthritis Cartilage. 2003;11(12):864–871.
44.
KompellaUBBandiNAyalasomayajulaSP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci. 2003;44(3):1192–1201.
45.
MacheinMRKullmerJRonickeV. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol. 1999;25(2):104–112.
46.
WolffJELaterraJGoldsteinGW. Steroid inhibition of neural microvessel morphogenesis in vitro: receptor mediation and astroglial dependence. J Neurochem. 1992;58(3):1023–1032.
47.
NauckMKarakiulakisGPerruchoudAPPapakonstantinouERothM. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341(2-3):309–315.
48.
GloddekJPagottoUPaezPMArztEStallaGKRennerU. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol. 1999;160(3):483–490.
49.
FinkenzellerGTechnauAMarmeD. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun. 1995;208(1):432–439.
50.
GilleJReisingerKWestphal-VargheseBKaufmannR. Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. J Invest Dermatol. 2001;117(6):1581–1587.
51.
LogieJJAliSMarshallKMHeckMMWalkerBRHadokePW. Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration. PLoS One. 2010;5(12):e14476.
52.
KrukowskiKEddyJKosikKLKonleyTJanusekLWMathewsHL. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun. 2011;25(2):239–249.
53.
EkstrandJHellstenJTingstromA. Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex. Neurosci Lett. 2008;442(3):203–207.
54.
LazarusAKeshetE. Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc. 2011;8(6):508–511.
55.
CaiJJiangWGAhmedABoultonM.Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res. 2006;71(1):20–31.
56.
ParkCWKimHWLimJH. Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice. Diabetes. 2009;58(11):2666–2676.
57.
SottileJ. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004;1654(1):13–22.
58.
van HinsberghVWKoolwijkP. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res. 2008;78(2):203–212.
59.
ClarkIMSwinglerTESampieriCLEdwardsDR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008;40(6-7):1362–1378.
60.
De PaivaCSCorralesRMVillarrealAL. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83(3):526–535.
61.
HakkiSSHakkiEENohutcuRM. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells. J Periodontal Res. 2009;44(6):794–802.
62.
LiuXHanQSunRLiZ. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis. Brain Res. 2008;1207:237–243.
63.
YigitOAciogluEGelisgenRServerEAAzizliEUzunH. The effect of corticosteroid on metalloproteinase levels of nasal polyposis. Laryngoscope. 2011;121(3):667–673.
64.
ZhangJBurridgeKAFriedmanMH. In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis. Am J Physiol Heart Circ Physiol. 2008;295(4):H1556–H1561.
65.
RibattiDNicoBVaccaARoncaliLDammaccoF. Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res. 2002;11(1):81–90.
66.
KajiKYoshijiHKitadeM. Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice. Hepatol Res. 2010;40(5):540–549.
67.
LaiLPenAHuY. Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor. Life Sci. 2007;81(7):570–576.
68.
MessaoudiSMilliezPSamuelJLDelcayreC. Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density. FASEB J. 2009;23(7):2176–2185.
